Weaver Gaines has over 40 years of entrepreneurial, management, and legal experience, including over 25 years as a founder, fund-raiser, and manager of start-up life science companies. Most recently, he was a co-founder and CEO
of OBMedical Company, a medical device company that developed and received FDA clearance for an electronic maternal fetal monitor, which was acquired by Philips Healthcare in 2018.
From 2008 to 2017, Gaines was Chairman of the Board of Nanotherapeutics, Inc. (now Ology Bioservices, Inc.), a specialty pharma
company and manufacturer of a bone extender cleared by the FDA. Prior that that, Gaines founded Ixion Biotechnology, a Florida-based, clinical-stage biotechnology company that developed stem cell and probiotic therapies focused on treatment of metabolic disorders. Ixion’s probiotic
technology was acquired by QMed AB in 2007.
Gaines received a BA from Dartmouth College and a JD from the University of Virginia School of Law and was an Infantry officer who served in Vietnam from 1969-70, with a final rank of Captain.
Co-Founder, President and COO
Blythe Karow has over 20 years of experience in medical device strategy, product development, product launch, and marketing. She has worked in multiple medical device areas
including neuromodulation, CRM, orthopedic, wound care, cardiovascular, image-guided interventions, women’s health, dermatology, spinal, and diagnostics. Her prior experience includes work both as a consultant and with medical device companies, ranging from startups to Fortune 100s, including Medtronic, J&J, and Boston Scientific.
Karow holds an MBA from the Darden Graduate School of Business Administration at the University of Virginia, where she also gained a certificate in Design Thinking, and a BS in Biomedical Engineering from Johns Hopkins University.
Chief Technology Officer
Euliano has spent the past 20 years leading teams developing medical devices and technology. He is the chief designer and manager of the FDA cleared Philips Healthcare VentAssist team that developed intelligent decision support software for ventilated patients. He holds over 40 US patents and has ten more pending. In addition, he has a long history in managing multi-disciplinary medical development teams and 19 years of experience managing R&D grants, including over $12M in industry and government funded research. His commercialization and entrepreneurial experience includes being the cofounder of two companies, both of which led to FDA clearance, commercial sales, and acquisition. He served as Chairman of the Board and CTO of OBMedical during their acquisition by Philips Healthcare. He has been involved in the successful FDA clearance of more than 6 medical devices. Euliano is currently a Senior Science Advisor to etectRX, a Senior Advisor to Philips Healthcare, and an Assistant Professor at the Department of Anesthesiology at the University of Florida.
Euliano holds a PhD in Signal Processing and Electrical Engineering, an MSEE in Electrical Engineering, and a BSE in Computer Science all from the University of Florida.